Plasmid construction
In non-integrating yeast vectors, auxotrophic markers are often placed under the control of the A. gossypii PTEF1 promoter. Thus, we first constructed an A. gossypii PTEF1-S. cerevisiae FEX1-TMFα1 cassette in the pITy backbone through two steps. First, primers 1 and 2 were used to append EcoRI and EagI sites to an A. gossypii PTEF1 fragment amplified from pSVA13 (Supplementary Table 3). This fragment and pITy A2aGH were digested with EcoRI-HF and EagI-HF and ligated to generate an intermediate pITy A. gossypii PTEF1 A2aGH construct. Second, primers 3 and 4 were used to amplify S. cerevisiae FEX1 from BJ5465 gDNA extracted using the protocol provided by Lõoke et al.44. This fragment and pITy A. gossypii PTEF1 A2aGH were digested with EagI-HF and AflII and ligated to generate pITy A. gossypii PTEF1-S. cerevisiae FEX1-TMFα1. USER45 cloning was used to subclone the A. gossypii PTEF1-S. cerevisiae FEX1-TMFα1 cassette, which was amplified using primers 5 and 6, into the pYC2/CT and pYES2 backbones amplified using primer pairs 7 and 8 and 8 and 9, respectively. The resulting constructs were named pCFEX1 A2aGH and pEFEX1 A2aGH, respectively. The A. gossypii PTEF1 promoters were swapped with PPGI1 and PREV1 promoters amplified from BJ5465 gDNA using primer pairs 10 and 11 and 12 and 13, respectively. pCFEX1 A2aGH and pEFEX1 A2aGH backbones were amplified using primer pairs 7 and 14 and 9 and 14, respectively, to mediate promoter swapping through USER cloning. The pCFEX2 and pEFEX2 backbones carry the PPGI1 promoter, and the pCFEX3 and pEFEX3 backbones carry the PREV1 promoter. The integrating pIFEX A2aGH construct was generated through USER cloning after amplifying pITy A2aGH using primers 15 and 16 and the A. gossypii PTEF1-S. cerevisiae FEX1-TMFα1 cassette using primers 5 and 6. The pIFEX A2aGH construct was designed to retain the NEO CDS to facilitate cloning in Escherichia coli using kanamycin; thus, the vector also confers G418 resistance to yeast. All constructs were sequence-verified using Sanger sequencing (Genewiz) and transformed into S. cerevisiae using the high-efficiency lithium acetate protocol46. We found that a recovery period is necessary to obtain yeast transformants using the FEX vectors. Following resuspension in YPD, transformed yeast cells were incubated at 30 °C for at least 3 h prior to plating on YPD plates containing 210.5 µM NaF. Yeast transformed with pIFEX A2aGH were plated on YPD supplemented with 10 mM NaF to promote increased gene dosage. The pRS315 PTEF1-yEGFP construct was generated from pRS315 PTEF1-yEGFP-Cln2, which was cloned for a separate study, in a series of steps. First, the pRS315 backbone was digested with EagI, blunted with Klenow fragment, and digested with SpeI. The PTEF1-yEGFP-Cln2 cassette was amplified from YEp351 PTEF1-yEGFP-Cln2 using universal M13 forward and reverse primers, then the amplicon was digested with SpeI to mediate directional cloning into pRS315. The backbone and insert were ligated and transformed into E. coli. Next, USER cloning mediated construction of pRS315 PTEF1-yEGFP from the Cln2-tagged plasmids. Primers 17 and 18 were used to amplify the plasmid excluding the Cln2 tag and introducing two stop codons at the 3′-end of the yEGFP coding sequence.
Yeast strains and culturing conditions
S. cerevisiae strain BJ5465 (Mata ura3-52 trp1 leu2∆1 his∆200 pep4::HIS3 prb∆1.6R can1) (ATCC) was used to construct the biocontainment strain BJ5465 fex1::GSHU ∆fex2 using the Delitto Perfetto method47. Primers 19 and 20 were used to integrate the GSHU cassette at the FEX1 locus, and primers 19 and 21 were used to integrate the CORE-Kp53 cassette into the FEX2 locus. Subsequently, primers 22 and 23 were used to remove the CORE-Kp53 cassette. Culture maintenance and gene expression were carried out using YPD medium at 30 °C with shaking at 225 r.p.m. Cultures harboring pCFEX and pEFEX plasmids were maintained in YPD supplemented with 2 mM NaF.
Fluorescence-activated cell sorting
Yeast cultures were diluted to an OD600 = 1.0 in 1× phosphate buffered saline (PBS) prior to all fluorescence-activated cell sorting (FACS) analyses. Approximately 60,000 cells were analyzed from each sample using a 488-nm laser and 530/30 nm bandpass filter using the gating strategy illustrated in Supplementary Fig. 4. All analyses were conducted using a BD FACSAria I flow cytometer and FlowJo v10. To analyze yEGFP expression, WT and biocontainment strains harboring pRS315 PTEF1-yEGFP were used to inoculate 5 mL synthetic dextrose medium supplemented with amino acids lacking leucine (SD -leu)47. Following overnight growth, cells were resuspended in 1× PBS and analyzed using FACS as described above. To analyze A2aR-GFP expression from pCFEX and pEFEX vector backbones, knockout strains carrying the vectors were first cultured overnight in YPD medium supplemented with 2 mM NaF at 30 °C with shaking at 225 r.p.m. Following overnight growth, each culture was subcultured into YP medium supplemented with 2% (w/v) raffinose (YPR) and 2 mM NaF at an initial OD600 of 0.5. Following ~10 h of shaking at 30 °C, each culture was subcultured into YP medium supplemented with 2% (w/v) raffinose, 2% (w/v) galactose (YPRG), and 2 mM NaF to induce A2aR-GFP expression. Cultures were incubated with shaking at 30 °C overnight prior to flow cytometric analysis. Analysis of A2aR-GFP expression from the pIFEX backbone was accomplished using a similar induction scheme in the absence of NaF. Knockout strains harboring integrated pIFEX A2aR-GFP cassettes were cultured in YPD medium overnight at 30 °C with shaking at 225 r.p.m. Subsequently, cultures were subcultured into YPR medium and incubated at 30 °C with shaking. After ~10 h, A2aR-GFP expression was induced in each culture through subculturing into YPRG medium and incubation at 30 °C with shaking overnight.
Dilution spotting
Yeast cultures were grown to an OD600 ~ 3 prior to dilution to an OD600 = 2.5 in sterile YPD. Diluted cells were used to prepare serial dilutions up to 10−5 in tenfold increments. A total of 5 µL of each dilution was spotted onto solid media using a multichannel pipette. Plates were allowed to dry at room temperature prior to overnight incubation at 30 °C.
Fluoride dose response assay
WT and biocontainment strain cultures were grown in biological triplicate overnight in YPD at 30 °C with shaking at 225 r.p.m. In the morning, the cultures were used to inoculate 5 mL fresh YPD at an initial OD600 of 0.15. Cultures were incubated with shaking at 30 °C for 7 h, reaching OD600 values near 2, and used to inoculate 3 mL YPD in individual wells of a 24-well block (Qiagen #19583) containing serially diluted concentrations of NaF and covered with a Breathe Easier sealing membrane (Sigma-Aldrich Z763624). Following overnight shaking at 30 °C, OD600 values were measured for cultures in each well.
Growth curves
To generate growth curves, the WT and biocontainment strains were used to inoculate 5 mL YPD cultures, which were grown overnight at 30 °C with shaking at 225 r.p.m. Cultures were used to inoculate 1 mL YPD in individual wells of a 24-well plate (Corning 3526), at an initial OD600 = 0.02. Cell growth was monitored using a Tecan Spark microplate reader maintained at 30 °C with orbital shaking at 180 r.p.m. and 3 mm amplitude. OD600 measurements were taken every 10 min with 50 ms settling time prior to each reading. Specific growth rates were calculated by fitting data to the logistic function48 (Eq. (1)):
$$N\left( t \right) = N_0 + \frac{{N_{{\mathrm{asymp}}} - N_0}}{{1 + e^{[k\left( {t_{\mathrm{c}} - t} \right)]}}},$$
(1)
where N0 is the initial number of cells, Nasymp is the maximal number of cells approached during stationary phase, k is the growth rate, and tc is the time at which the growth curve exhibits an inflection point.
Escape rate determination
To determine the escape rate, the biocontainment strain was grown overnight in biological triplicate in YPD at 30 °C with shaking at 225 r.p.m. In the morning, ~50 colony forming units (CFUs) of each replicate culture were plated onto YPD media assuming a conversion factor of 107 CFU/mL/OD600. Using the same conversion factor, 108 and 109 CFUs of each replicate culture were plated onto YPD supplemented with 210.5 µM and 5 mM NaF. Following incubation of plates at 30 °C for 2 days, CFUs were counted. The CFU values obtained for the YPD control plates were used to correct the CFU/mL/OD600 conversion factor and to calculate the total number of cells plated on each plate.
pH Buffering experiment
Individual colonies were used to inoculate 5 mL YPD medium. Cultures were grown overnight at 30 °C with shaking at 225 r.p.m. Following overnight growth, cells were used to inoculate YPR at an initial OD600 = 0.2. Cultures were grown for 7–8 h at 30 °C with shaking at 225 r.p.m. and used to inoculate 5 mL YPRG supplemented with 10 mM NaF at an initial OD600 = 0.2. One set of cultures were used to inoculate 5 mL YPRG buffered to pH = 6 using 100 mM MES (Sigma-Aldrich, St. Louis, MO, USA). Following overnight growth, cells were prepared for FACS analysis as described above.
Microbiostatic/microbiocidal assay
WT and biocontainment strain cultures were grown overnight and subcultured into 5 mL YPD at an initial OD600 of 0.1. Cultures were incubated with shaking at 30 °C for ~10 h to an OD600 between 2 and 4 and used to inoculate 3 mL YPD in individual wells of a 24-well block containing serially diluted concentrations of NaF and covered with a Breathe Easier sealing membrane. Following overnight incubation with shaking at 30 °C, the OD600 values were measured for cultures in each well. The equivalent of 0.2 OD-mL of cells were spun at 3000 × g for 30 s, washed with sterile 1× PBS, and used to inoculate 3 mL fresh YPD in a sterile well of a 24-well block, which was covered with a Breathe Easier sealing membrane. Upon overnight growth, the OD600 values were measured for cultures in each well.
Modeling cellular fluoride uptake
Fluoride uptake was approximated by modeling the transport of HF across the cell membrane. First, the concentration of HF in bulk is calculated from the exogenous NaF concentration using Eq. (2):
$$\left[ {{\mathrm{HF}}} \right] = \frac{{[{\mathrm{NaF}}]}}{{\left( {\frac{{10^{ - 3.17}}}{{10^{ - pH}}}} \right) + 1}}.$$
(2)
The above equation takes into account the pKa of HF at 25 °C, which is equal to 3.17. Next, the general transport equation (Eq. (3)) can be solved for the time-dependent concentration of NaF inside of the cell:
$$\frac{{\partial C}}{{\partial t}} = D\nabla ^2C,$$
(3)
where C is the time-dependent concentration of fluoride and D is the diffusion coefficient of fluoride. Solving Eq. (3) for C:
$$C_{\mathrm{i}}\left( t \right) = C_0\left( {1 - e^{ - \frac{{AP}}{V}t}} \right),$$
(4)
where Ci(t) is the intracellular fluoride concentration, C0 is the bulk fluoride concentration, A is the membrane surface area, P is the permeability constant, and V is the cell volume. The permeability constant used for HF in the cell membrane is 0.0002 cm/s as calculated by Gutknecht et al.49. The cell surface area and volume were estimated from figures provided on bionumbers.hms.harvard.edu.
Now, the fluoride concentrations can be used to solve for the flux, J, of fluoride across the cell:
$$J = - P(C_{\mathrm{i}} - C_0),$$
(5)
$$J = PC_0e^{ - \frac{{AP}}{V}t}.$$
(6)
Now, Eq. (6) gives the flux of fluoride across the cell membrane given a bulk concentration of fluoride, which is dictated by the exogenous NaF concentration as calculated in Eq. (2).
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Comments
Something to say?
Log in or Sign up for free